Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Johannes Liebig"'
Autor:
Nina Hahn, Debbra Y. Knorr, Johannes Liebig, Liane Wüstefeld, Karsten Peters, Marita Büscher, Gregor Bucher, Hannelore Ehrenreich, Ralf Heinrich
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 10 (2017)
The cytokine erythropoietin (Epo) mediates various cell homeostatic responses to environmental challenges and pathological insults. While stimulation of vertebrate erythrocyte production is mediated by homodimeric “classical” Epo receptors, alter
Externí odkaz:
https://doaj.org/article/e042bc63a4c54c19bbf30a8e66f5936c
Autor:
Teresa G Krieger, Alexander Sudy, Felix Schicktanz, Luca Tosti, Johannes Liebig, Björn Konukiewitz, Morgane Rouault, Anežka Niesnerová, Xiaoyan Qian, Wilko Weichert, Roland Eils, Katja Steiger, Christian Conrad
Tumour heterogeneity remains a major obstacle to effective and precise therapy for pancreatic ductal adenocarcinoma (PDAC), the most common pancreatic cancer. Several transcriptional subtypes of PDAC with differential prognosis have been described, b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fb1d41c7aefdf7129ebaeaac6ec3264
https://doi.org/10.1101/2022.09.23.509133
https://doi.org/10.1101/2022.09.23.509133
Autor:
Leif E. Sander, Vladimir Gonçalves Magalhães, Sebastian Stricker, Saskia Trump, Irina Lehmann, Sven Laudi, Sven Klages, Johannes Liebig, Victor M. Corman, Jennifer Loske, Roland Eils, Soeren Lukassen, Bernd Timmermann, Marcus A. Mall, Christian Conrad, Markus Ralser, Anke Seegebarth, Marey Messingschlager, Birgit Sawitzki, Marco Binder, Jobst Röhmel, Loreen Thürmann, Robert Lorenz Chua
Publikováno v:
Nature Biotechnology
Children have reduced severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection rates and a substantially lower risk for developing severe coronavirus disease 2019 compared with adults. However, the molecular mechanisms underlying protec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecfb2677a3de000e1b18b5a18645c153
https://doi.org/10.1101/2021.06.24.21259087
https://doi.org/10.1101/2021.06.24.21259087
Autor:
Fabian Pott, Marco Binder, Martin Witzenrath, Christine Goffinet, Sven Laudi, Leif E. Sander, Irina Lehmann, Teresa G Krieger, Saskia Trump, Loreen Thürmann, Johannes Liebig, Sara Hadzibegovic, Robert Lorenz Chua, Uwe G. Liebert, Jan Philipp Albrecht, Lars Kaderali, Sven Twardziok, Christian Conrad, Bianca P Hennig, Bettina Heidecker, Jennifer Loske, Alessia Lena, Markus S. Anker, Naveed Ishaque, Soeren Lukassen, Christian Drosten, Maria Theresa Völker, Christina Klasa, Sarah Dorothea Müller, Marey Messingschlager, Roland Eils, Florian Kurth, Ulf Landmesser, Victor M. Corman, Julia Kazmierski, Jürgen Eils
In COVID-19, hypertension and cardiovascular diseases have emerged as major risk factors for critical disease progression. Concurrently, the impact of the main anti-hypertensive therapies, angiotensin-converting enzyme inhibitors (ACEi) and angiotens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f9c069c41af30f3665a116e93ee3444
https://doi.org/10.1101/2020.09.22.20199471
https://doi.org/10.1101/2020.09.22.20199471
Autor:
Felix Balzer, Bernd Timmermann, Saskia Trump, Naveed Ishaque, Jürgen Eils, Olivia Debnath, Sven Twardziok, Loreen Thürmann, Christian Conrad, Jennifer Loske, Fabian Pott, Uwe G. Liebert, Alexander Krannich, Christof von Kalle, Martin Witzenrath, Sein Schmidt, Robert Lorenz Chua, Florian Kurth, Andreas C. Hocke, Sven Laudi, Christian Drosten, Maria Theresa Völker, Norbert Suttorp, Roland Eils, Stefan Schneider, Irina Lehmann, Melanie Maier, Soeren Lukassen, Daniel Wendisch, Christine Goffinet, Julia Kazmierski, Holger Müller-Redetzky, Leif E. Sander, Felix Machleidt, Bianca P Hennig, Johannes Liebig
Publikováno v:
Nature Biotechnology
To investigate the immune response and mechanisms associated with severe coronavirus disease 2019 (COVID-19), we performed single-cell RNA sequencing on nasopharyngeal and bronchial samples from 19 clinically well-characterized patients with moderate
Autor:
Loreen Thürmann, Felix Balzer, Jennifer Loske, Bernd Timmermann, Alexander Krannich, Robert Lorenz Chua, Florian Kurth, Christof von Kalle, Sven Laudi, Andreas C. Hocke, Christian Conrad, Johannes Liebig, Martin Witzenrath, Bianca P Hennig, Olivia Debnath, Fabian Pott, Roland Eils, Irina Lehmann, Soeren Lukassen, Naveed Ishaque, Felix Machleidt, Jürgen Eils, Sein Schmidt, Christian Drosten, Julia Kazmierski, Holger Müller-Redetzky, Christine Goffinet, Daniel Wendisch, Stefan Schneider, Sven Twardziok, Saskia Trump, Leif-Erik Sander
The clinical course of COVID-19 is highly variable, however, underlying host factors and determinants of severe disease are still unknown. Based on single-cell transcriptomes of nasopharyngeal and bronchial samples from clinically well-characterized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::354dc25bda203d8d6976f9de93007f43
https://doi.org/10.1101/2020.04.29.20084327
https://doi.org/10.1101/2020.04.29.20084327
Autor:
Nina, Hahn, Debbra Y, Knorr, Johannes, Liebig, Liane, Wüstefeld, Karsten, Peters, Marita, Büscher, Gregor, Bucher, Hannelore, Ehrenreich, Ralf, Heinrich
Publikováno v:
Frontiers in Molecular Neuroscience
The cytokine erythropoietin (Epo) mediates various cell homeostatic responses to environmental challenges and pathological insults. While stimulation of vertebrate erythrocyte production is mediated by homodimeric “classical” Epo receptors, alter
Autor:
Sven Twardziok, Irina Lehmann, Sven Laudi, Johannes Liebig, Robert Lorenz Chua, Soeren Lukassen, Sarah Dorothea Müller, Bettina Heidecker, Marco Binder, Jennifer Loske, Martin Witzenrath, Florian Kurth, Christine Goffinet, Christina Klasa, Jan Philipp Albrecht, Teresa G Krieger, Uwe G. Liebert, Saskia Trump, Leif E. Sander, Loreen Thürmann, Julia Kazmierski, Sara Hadzibegovic, Thore Bürgel, Marey Messingschlager, Alessia Lena, Christian Drosten, Maria Theresa Völker, Victor M. Corman, Ulf Landmesser, Jürgen Eils, Markus S. Anker, Naveed Ishaque, Lars Kaderali, Roland Eils, Fabian Pott, Jakob Steinfeldt, Christian Conrad, Bianca P Hennig
Publikováno v:
Nature Biotechnology
In coronavirus disease 2019 (COVID-19), hypertension and cardiovascular diseases are major risk factors for critical disease progression. However, the underlying causes and the effects of the main anti-hypertensive therapies-angiotensin-converting en